These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21750979)

  • 1. Multisite-directed inhibitors of protein kinase CK2: new challenges.
    Świder R; Masłyk M; Martín-Santamaría S; Ramos A; de Pascual-Teresa B
    Mol Cell Biochem; 2011 Oct; 356(1-2):117-9. PubMed ID: 21750979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of CK2 inhibitors.
    Makowska M; Łukowska-Chojnacka E; Wińska P; Kuś A; Bilińska-Chomik A; Bretner M
    Mol Cell Biochem; 2011 Oct; 356(1-2):91-6. PubMed ID: 21750983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors.
    Oramas-Royo S; Haidar S; Amesty Á; Martín-Acosta P; Feresin G; Tapia A; Aichele D; Jose J; Estévez-Braun A
    Bioorg Chem; 2020 Jan; 95():103520. PubMed ID: 31887475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
    Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
    Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
    Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
    Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
    Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M
    Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
    Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
    Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
    Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
    Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
    Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new family of densely functionalized fused-benzoquinones as potent human protein kinase CK2 inhibitors.
    Martín-Acosta P; Haider S; Amesty Á; Aichele D; Jose J; Estévez-Braun A
    Eur J Med Chem; 2018 Jan; 144():410-423. PubMed ID: 29288942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dark side of protein kinase CK2 inhibition.
    Cozza G; Meggio F; Moro S
    Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
    Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M
    Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2.
    Syniugin AR; Ostrynska OV; Chekanov MO; Volynets GP; Starosyla SA; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):160-169. PubMed ID: 27590574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
    Bretner M; Najda-Bernatowicz A; Łebska M; Muszyńska G; Kilanowicz A; Sapota A
    Mol Cell Biochem; 2008 Sep; 316(1-2):87-9. PubMed ID: 18548199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase.
    Chojnacki K; Lindenblatt D; Wińska P; Wielechowska M; Toelzer C; Niefind K; Bretner M
    Bioorg Chem; 2021 Jan; 106():104502. PubMed ID: 33317841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.